Type 2 & other diabetes

Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study

Diabetes MetabPublished Retrospective cohort study

Authors' conclusion

Diuretic treatment weighting may be associated with increased risk of MALEs. We identified several markers of increased risk of limb events where the use of diuretics should be considered with caution.

Study context

Population
Consecutive T2D patients without cardiovascular history referred for cardiovascular check-ups; 59.5 ± 10.7 years, 51 % females, diabetes duration 9.1 ± 8.5 years
Participants
1,309 patients
Exposure
Diuretics vs no diuretics
  • Diureticsn = 402
Outcome
MALEs (and amputation alone)
Follow-up
3.8 ± 1.64 years
Methodological detailsobservational, Cox models, propensity score, IPTW analysis
  • Observational
  • Cox models
  • Propensity score
  • IPTW analysis

Main finding

As reported in the abstract

MALEs
Diuretics vs No diureticsAdjusted hazard ratio (95 % CI)P value
Multivariable analysis
1.96(1.32–2.91)
P = 0.001
Adjusted on propensity score
1.66(1.08–2.56)
P = 0.02
IPTW analysis
1.76(1.67–1.84)
P < 0.0001
Major adverse limb events (MALEs), all patients
121 (9.1 %)
Amputations, all patients
19 (1.4 %)

Observational data: associations, not effects.

Further findings

OutcomeaHR (CI)P value
MALEs with abnormal ankle-brachial index at baseline2.29 (1.32–3.96)P = 0.003

MALEs by diuretic class

aHR (CI)P value
Loop diuretics2.56 (1.16–5.64)P = 0.020
Thiazides2.21 (1.37–3.57)P = 0.001
Potassium sparing diuretics2.56 (1.16–5.64)P = 0.020

Death · proportions of deaths, as printed

P = 0.001

Death — Deaths, all patients
111

Original publication

Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study. Diabetes Metab. Published 3 October 2024. doi:10.1016/j.diabet.2024.101582

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.